赖氨酰氧化酶样蛋白2(LOXL2)重组蛋白
Recombinant Lysyl Oxidase Like Protein 2 (LOXL2)
LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14
- 编号RPF552Ra01
- 物种Rattus norvegicus (Rat,大鼠) 相同的名称,不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量13.9kDa
- 实际分子量16kDa(差异分析请参阅说明书)
- 片段与标签Phe434~Ser546 with N-terminal His Tag
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性状冻干粉
- 纯度> 97%
- 等电点6.7
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1104 ¥ 2760 ¥ 5520 ¥ 16560 ¥ 41400
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Rattus norvegicus (Rat,大鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPF552Ra02 | 赖氨酰氧化酶样蛋白2(LOXL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPF552Ra01 | 赖氨酰氧化酶样蛋白2(LOXL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAF552Ra02 | 赖氨酰氧化酶样蛋白2(LOXL2)多克隆抗体 | WB; IHC; ICC; IP. |
PAF552Ra01 | 赖氨酰氧化酶样蛋白2(LOXL2)多克隆抗体 | WB; IHC; ICC; IP. |
LAF552Ra81 | 赖氨酰氧化酶样蛋白2(LOXL2)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
LAF552Ra71 | 赖氨酰氧化酶样蛋白2(LOXL2)多克隆抗体(生物素标记) | WB; IHC; ICC. |
SEF552Ra | 赖氨酰氧化酶样蛋白2(LOXL2)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMF552Ra | 赖氨酰氧化酶样蛋白2(LOXL2)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
BMC Cancer. | Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 [Pubmed: 24007603] |
Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818] |
Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380] |
BMC Cancer | Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study [Pubmed:29558905] |
Laryngoscope | Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma [Pubmed: 31219623] |
留言咨询